As Director of Genome Analytics at AstraZenecas Centre for Genomics Research, Jonathan applies his passion for solving scientific problems to improve healthcare. He leads a team analyzing large-scale multi-omic datasets to accelerate drug discovery, drawing on his expertise and PhD from the University of Leeds.
His team utilizes one of the worlds largest full-genome databases linked with patient health records to identify novel drug targets for future medicines.
Jonathan Mitchell
Director Genome Analytics at AstraZeneca
London, England, United Kingdom
Overview
Topics They Care About
Genomics in Healthcare
Leads the Genome Analytics team at AstraZeneca, focusing on using large-scale genomic and multi-omic data to discover new medicines and improve patient health.
Large-Scale Datasets
His work involves analyzing massive full-genome and health record databases to derive insights into the genetic basis of disease.
Drug Discovery
His team's genomic analysis directly informs the identification of novel drug targets, aligning with his stated passion for accelerating the delivery of new medicines.
Media Appearances
Research Seminar: Ella Whittle and Jonathan Mitchell. Featured in Genomics England
Work History
8-2025
Director Genome Analytics at AstraZeneca
11-2022 - 8-2025
Associate Principal Scientist at AstraZeneca
2-2021 - 11-2022
Senior Scientist at AstraZeneca
3-2019 - 2-2021
Senior Cancer Analyst at Genomics England
5-2017 - 2-2019
Senior Researcher at Eurac Research
3-2014 - 3-2016
Bioinformatics Researcher at The Institute of Cancer Research
1-2011 - 1-2014
Postdoctoral Researcher at EPFL
Education
2006 - 2011
Doctor of Philosophy (PhD) from University of Leeds
2001 - 2006
Bachelor of Science - BS from University of Strathclyde
More Information
Social Presence :
Prographics :
Exp : 13
Location : London, England, United Kingdom
Job Level : Mid-senior
Designation : Director Genome Analytics at AstraZeneca
